LLY compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

EWTXEdgewise Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

EWTXEdgewise Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

EWTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.6%▲+3.57%×0.31

Q2 FY26±11.6%▼−1.27%×0.11

= impliedLLY realized, solidEWTX realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

May 7 '26

±8.8%

▼−3.81%

×0.43

Q1 FY26±13.2%▼−1.53%×0.11

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

EWTXEdgewise Therapeutics, Inc.

45.13▲+16.09%· post 45.08

ClosedNov 6 '26

Mkt cap$4.9BRevenue—Revenue—

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

EWTXEdgewise Therapeutics, Inc.

1,360.90▼−0.28%post 1,358.90

Price

45.13▲+16.09%post 45.08

$1.2T

Mkt cap

$4.9B

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,360.90▼−0.28%vsEWTX45.13▲+16.09%ClosedNov 6 '26